CARGO Therapeutics, Inc. (CRGX)

SolarWinds Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-221.78	-167.5	-98.15	-40.95	-5.85
Depreciation & Amortization	4.94	7.07	3.69	1.44	0.15
Loss (Gain) From Sale of Assets	0.16	0.16	-	-	-
Asset Writedown & Restructuring Costs	11.01	0.3	1.51	1.01	-
Loss (Gain) From Sale of Investments	-1.36	-3.52	-	-	-
Stock-Based Compensation	21.9	17.97	3.33	0.3	0.51
Other Operating Activities	-	-	6.25	6.16	-
Change in Accounts Payable	2.11	-2.1	0.76	2.82	0.33
Change in Other Net Operating Assets	-6.57	7.87	1.45	0.15	-0.08
Operating Cash Flow	-189.59	-139.74	-81.16	-29.07	-4.94
Capital Expenditures	-2.18	-4.45	-8.28	-2.72	-0.44
Sale of Property, Plant & Equipment	0.22	0.22	-	-	-
Sale (Purchase) of Intangibles	-1.31	-0.95	-0.72	-0.56	-
Investment in Securities	146.75	-299.91	-	-	-
Investing Cash Flow	143.49	-305.08	-8.99	-3.28	-0.44
Short-Term Debt Issued	-	-	3.5	28.45	-
Total Debt Issued	-	-	3.5	28.45	-
Net Debt Issued (Repaid)	-	-	3.5	28.45	-
Issuance of Common Stock	0.73	104.06	296.64	0.23	-
Other Financing Activities	-0.46	-0.59	-5.47	-	-
Financing Cash Flow	0.27	103.47	494.58	34.19	5.41
Net Cash Flow	-45.84	-341.35	404.43	1.83	0.03
Free Cash Flow	-191.77	-144.19	-89.44	-31.8	-5.38
Free Cash Flow Per Share	-4.00	-3.21	-15.06	-81.06	-35.32
Levered Free Cash Flow	-80.51	-93.51	-68.1	-7.91	-
Unlevered Free Cash Flow	-80.51	-93.51	-67.1	-4.82	-
Change in Net Working Capital	6.87	-3.95	4.68	-18.45	-

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q